Industry news 🗞 Eli Lilly and Company wins long-awaited FDA approval for Alzheimer’s drug, donanemab, which will be marketed as Kisunla. Read the full story here: https://lnkd.in/ew3w8MdM #alzheimers #fda #lifesciences #industrynews #pharmanews
Mix Talent’s Post
More Relevant Posts
-
Industry news 📰 Congratulations to Verona Pharma on the FDA approval of Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. #copd #fdaapproval #lifesciencesnews #pharmanews #lifesciences
BREAKING NEWS: Today, the US FDA approved our drug for the maintenance treatment of #COPD in adults, making it the first inhaled product with a novel mechanism of action for this indication in over 20 years. Learn more: https://bit.ly/4bnUSxt #FDAApproval
To view or add a comment, sign in
-
Did we ‘sparq’ your interest? 💡 Check out our whitepaper by Chad Thompson, Ph.D. on best practices for building resilience in pharma and biotech sales and learn more about Mix Talent's proprietary tool developed and validated specifically for pharma/biotech sales reps: https://lnkd.in/gkf7mhK6 If you're interested in incorporating these concepts into your talent acquisition or talent management practices, reach out to Chad directly or comment below ⬇ #talentacquisition #pharma #biotech #lifesciences #lifesciencesrecruitment #lifesciencesjobs #pharmaceuticalsales
To view or add a comment, sign in
-
-
Industry news 📰 Congratulations to argenx, who announced the FDA approval of VYVGART® Hytrulo - for the treatment of adult patients with chronic inflammatory demyelinating polyneuropathy (CIDP). #raredisease #autoimmune #lifesciencesnews #lifesciences #biotech #CIDP
Today we announced the FDA approval of a new treatment for adults with chronic inflammatory demyelinating polyneuropathy (CIDP). This approval marks a key advancement in the understanding of rare, autoimmune diseases, and we are proud to deliver a new, innovative option for the #CIDP community. #TogetherWeDiscover Learn more: https://bit.ly/45D76Rl
Learn More
us.argenx.com
To view or add a comment, sign in
-
Today is the summer solstice ☀ and is recognized as "The Longest Day" by the Alzheimer's Association. On this day, people from across the world will celebrate the thousands of people who are fighting the darkness of Alzheimer’s by raising funds and awareness for care, support, and research. In previous years, our teammates shared their personal Longest Day stories to honor their family members, we encourage you to read them below and share your own stories with us: Theresa Ann Karwoski – Grandma to Our Big, Loving Family https://lnkd.in/g7eB_6Ka Juan Sibemhart - Abuelo, Professor, Historian https://lnkd.in/g964qm3r Chip Purdy - Marine, Golfer, Family Man https://lnkd.in/d7bzDtsT Ralph Perdew - Fireman, Chaplain, Dance Extraordinaire https://lnkd.in/efj8jPND Cathy Halligan - Mom to me, Mama Halligan to many https://lnkd.in/e5yFG3sS Don Shimp, Everyone’s Favorite Uncle https://lnkd.in/es2Gb-BK #alzheimersawareness #alzheimersdisease #alzheimers #summersolstice
-
-
-
-
-
+2
To view or add a comment, sign in
-
-
Industry news🗞Congratulations to Botanix Pharmaceuticals on the approval of Sofdra to treat primary axillary hyperhidrosis. #lifesciences #pharma #pharmanews #dermatology #biotech
📣 FDA Approves Sofdra™ topical gel #Botanix is very pleased to announce the US FDA approval of Sofdra™ (sofpironium) topical gel, 12.45%. Sofdra is a prescription medicine used to treat primary axillary hyperhidrosis (excessive underarm sweating) in adults and children 9 years and older. View ASX release 👉 https://lnkd.in/gzHx8Q9k $BOT #ASX #dermatology #pharmaceuticals #pharma #biotech #innovation #hyperhidrosis #launch
To view or add a comment, sign in
-
-
At Mix Talent we specialize in connecting talented candidates with top life science organizations who are actively growing their teams and we want to help you find what's next! Get in the Mix by joining our Talent Network and put yourself on the radar of companies looking for their next team member. Join today: https://lnkd.in/gTqfUCRE #newjob #careeropportunities #lifesciences #biotech #pharma #healthtech #pharmajob #dtx #medtech
To view or add a comment, sign in
-
When we were engaged to lead a commercial sales build for an anticipated product approval and launch, we had one goal: Deliver. And then some. Our team stepped up to plan in-person and virtual hiring events, schedule interviews and assessments, and develop interview guides for several roles, including Areas Business Leaders, Access and Reimbursement Managers, and Neurology Account Specialists. That’s what you call a #winwin. #lifesciences #casestudy #talentacquisition #findyourrightmix #biotech #pharma #pharmasales
To view or add a comment, sign in
-
Mickey Shimp and Christopher Sauls attended the 2024 Biotechnology Innovation Organization Convention last week where optimism surrounding the life sciences was abundant! Interested in hearing more about Christopher's experience or learning more about Mix Talent? Connect with him today! #BIO2024 #lifesciences
Loving all the optimism at the BIO 2024 Convention.
To view or add a comment, sign in
-
-
Eddie Pauline, MBA, OhioCED, president of Ohio Life Sciences, shares insight from Amgen Ohio's Vice President of Site Operations about their growth, success, and approach to both science and business here in Central Ohio. We are proud to be headquartered in Ohio where there is much excitement and growth in the life sciences, particularly around pediatric care, medical device manufacturing, cell and gene therapy, and research. #ohiolifesciences #lifesciences #columbusohio #midwest #ohio #biotech https://lnkd.in/ed9PfvCS
Amgen’s Growth in Ohio
Eddie Pauline, MBA, OhioCED on LinkedIn
To view or add a comment, sign in